Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
... Designed to meet the needs ... animal component-free medium supports fast ... cell densities, while maintaining high ... protein production using the Baculovirus ...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... LIC Duet™ Trx•Tag™ Ek Adaptor encodes a ... binding site (rbs), ATG translation initation codon, ... Trx•Tag is a 109 aa sequence that ... been demonstrated to enhance solubility of many ...
Biology Products:(Date:12/4/2009)... 4 Stemline Therapeutics, Inc. today announced that data from ... in both in vitro and animal models of ... presentation at the upcoming 51st Annual Meeting of the American ... from December 5-8, 2009. The poster will be presented by ...
(Date:12/3/2009)... JourneyLite of Houston, LLC announced today ... a second surgical option, vertical sleeve gastrectomy , ... currently performs. The first sleeve gastrectomy procedure at the ... Laurent, MD on October 20, 2009. The patient ...
(Date:12/3/2009)... PHARMACEUTICALS, INC. (OTC Bulletin Board: ... launch of MuGard, an FDA approved treatment for oral ... chemotherapy. MuGard is commercially launched by Access, partner, SpePharm, ... Norway, Greece and Sweden. Access is conducting pre-marketing activities, ...
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the ... of five lots and voluntary market withdrawal of one ... . Shire is taking this action because some Daytrana ... not meet their release liner removal specification, and as ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5